Bank Julius Baer & Co’s Co-Diagnostics CODX Stock Holding History

Bank Julius Baer & Co’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,442	Closed	-$699K	–	829
2021 Q1	$699K	Sell	2,442 -3,264	-57%	-$1.3M	0.01%	386
2020 Q4	$1.59M	Buy	5,706 +4,926	+632%	+$1.82M	0.01%	285
2020 Q3	$318K	Buy	780 +757	+3,291%	+$389K	﹤0.01%	449
2020 Q2	$14K	Sell	23 -24	-51%	-$11K	﹤0.01%	617
2020 Q1	$11K	Buy	+47	New	+$8.15K	﹤0.01%	602

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ARC

Advisor Resource Council Dallas, Texas $309M AUM 22.32% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank Julius Baer & Co's CODX Position: Q2 2021 in Review

Bank Julius Baer & Co sold out of Co-Diagnostics (CODX) in Q2 2021, closing a stake of 2,442 shares — an estimated $699K sold.

Bank Julius Baer & Co first reported a position in CODX in Q1 2020 and held it in 5 quarters. The position peaked at $1.59M in Q4 2020. 88 funds tracked by Wall St. Rank hold CODX as of Q2 2021.

Bank Julius Baer & Co reported no remaining Co-Diagnostics position as of Q2 2021 after selling out during the quarter.
Bank Julius Baer & Co sold 2,442 Co-Diagnostics shares in Q2 2021, an estimated $699K.
Bank Julius Baer & Co first reported a position in Co-Diagnostics in Q1 2020 and held it in 5 quarters.
Bank Julius Baer & Co's Co-Diagnostics position peaked at $1.59M in Q4 2020.
88 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2021.

Based on Bank Julius Baer & Co's 13F filing for Q2 2021, filed 23 Jul 2021.